Moody National Bank Trust Division Vertex Pharmaceuticals Inc Transaction History

Moody National Bank Trust Division

$922 Million
Q3 2024

A detailed history of Moody National Bank Trust Division transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Moody National Bank Trust Division holds 3,661 shares of VRTX stock, worth $1.7 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

3,661

Previous 3,688 0.73%

Holding current value

$1.7 Million

Previous $1.73 Million 1.5%

% of portfolio

0.18%

Previous 0.14%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$460.0 - $505.78 $12,420 - $13,656	-27 Reduced 0.73%	3,661 $1.7 Million
Q2 2024 Jul 03, 2024	BUY	$392.81 - $485.53 $43,601 - $53,893	111 Added 3.1%	3,688 $1.73 Million
Q1 2024 Apr 04, 2024	BUY	$407.69 - $446.08 $4,484 - $4,906	11 Added 0.31%	3,577 $1.5 Million
Q4 2023 Jan 11, 2024	SELL	$343.0 - $410.68 $1.01 Million - $1.21 Million	-2,952 Reduced 45.29%	3,566 $1.45 Million
Q3 2023 Oct 12, 2023	BUY	$338.18 - $362.46 $273,587 - $293,230	809 Added 14.17%	6,518 $2.27 Million
Q2 2023 Jul 07, 2023	BUY	$314.42 - $351.91 $18,865 - $21,114	60 Added 1.06%	5,709 $2.01 Million
Q1 2023 Apr 19, 2023	SELL	$283.23 - $323.1 $2,265 - $2,584	-8 Reduced 0.14%	5,649 $1.78 Million
Q4 2022 Jan 11, 2023	BUY	$285.76 - $321.48 $2,571 - $2,893	9 Added 0.16%	5,657 $1.63 Million
Q2 2022 Jul 07, 2022	SELL	$234.96 - $292.55 $153,663 - $191,327	-654 Reduced 10.38%	5,648 $1.59 Million
Q1 2022 Apr 12, 2022	SELL	$221.42 - $260.97 $175,807 - $207,210	-794 Reduced 11.19%	6,302 $1.64 Million
Q4 2021 Jan 13, 2022	SELL	$177.01 - $223.45 $3.96 Million - $5 Million	-22,379 Reduced 75.93%	7,096 $1.56 Million
Q3 2021 Oct 07, 2021	SELL	$181.39 - $202.99 $3,446 - $3,856	-19 Reduced 0.06%	29,475 $5.35 Million
Q2 2021 Jul 13, 2021	SELL	$187.49 - $221.1 $70,121 - $82,691	-374 Reduced 1.25%	29,494 $5.95 Million
Q1 2021 Apr 14, 2021	BUY	$207.02 - $241.31 $21,116 - $24,613	102 Added 0.34%	29,868 $6.42 Million
Q4 2020 Mar 04, 2021	BUY	$207.01 - $276.09 $24,220 - $32,302	117 Added 0.39%	29,766 $7.04 Million
Q2 2020 Jul 10, 2020	BUY	$225.48 - $295.8 $21,420 - $28,101	95 Added 0.32%	29,649 $8.61 Million
Q3 2019 Oct 18, 2019	BUY	$166.23 - $187.09 $14,129 - $15,902	85 Added 0.29%	29,554 $5.01 Million
Q1 2019 Apr 11, 2019	BUY	$163.73 - $194.7 $2,455 - $2,920	15 Added 0.05%	29,469 $5.42 Million
Q4 2018 Jan 07, 2019	BUY	$151.91 - $192.21 $27,191 - $34,405	179 Added 0.61%	29,454 $4.88 Million
Q3 2018 Oct 31, 2018	BUY	$167.73 - $192.74 $4.45 Million - $5.12 Million	26,560 Added 978.27%	29,275 $5.64 Million
Q1 2018 Apr 16, 2018	BUY	$151.6 - $177.13 $213,301 - $249,221	1,407 Added 107.57%	2,715 $442,000
Q4 2017 Jan 18, 2018	BUY	$137.28 - $155.55 $179,562 - $203,459	1,308	1,308 $417,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody National Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Moody National Bank Trust Division with notifications on news.

Account

Moody National Bank Trust Division Vertex Pharmaceuticals Inc Transaction History